JANUET XR 501000 MG TABLETS Israel - inglés - Ministry of Health

januet xr 501000 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 1000 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

JANUET XR 501000 MG TABLETS Israel - inglés - Ministry of Health

januet xr 501000 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 1000 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

JANUET XR 50500 MG TABLETS Israel - inglés - Ministry of Health

januet xr 50500 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 500 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

JANUET XR 50500 MG TABLETS Israel - inglés - Ministry of Health

januet xr 50500 mg tablets

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - tablets extended release - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 500 mg - metformin - januet xr is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate

FOSAVANCE 70 MG5600 I.U. TABLETS Israel - inglés - Ministry of Health

fosavance 70 mg5600 i.u. tablets

organon pharma israel ltd., israel - alendronic acid as alendronate sodium trihydrate; colecalciferol - tablets - colecalciferol 140 mcg; alendronic acid as alendronate sodium trihydrate 70 mg - colecalciferol - fosavance is indicated for : - treatment of osteoporosis in postmenopausal women: fosavance increases bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). - treatment to increase bone mass in men with osteoporosis.

RELTONE 200 MG- ursodiol capsule
RELTONE 400 MG- ursodiol capsule Estados Unidos - inglés - NLM (National Library of Medicine)

reltone 200 mg- ursodiol capsule reltone 400 mg- ursodiol capsule

intra-sana laboratories - ursodiol (unii: 724l30y2qr) (ursodiol - unii:724l30y2qr) - reltone™ is a bile acid available as 200 mg and 400 mg capsules suitable for oral administration. ursodiol (ursodesoxycholic acid) is a naturally occurring bile acid found in small quantities in normal human bile and in the bile of certain other mammals. it is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. the chemical name for ursodiol is 3α,7β-dihydroxy-5β-cholan-24-oic acid (c24 h40 o4 ). ursodiol has a molecular weight of 392.57. its structure is shown below: inactive ingredients: silicon dioxide, magnesium stearate, and corn starch. gelatin capsules contain gelatin and titanium dioxide and are printed with edible black ink; additionally, the 400 mg capsule also contains fd&c yellow #6 and d&c yellow #10.

Exluton Tablets 0.5 Tanzania - inglés - Tanzania Medicinces & Medical Devices Authority

exluton tablets 0.5

organon south africa (pty) ltd, south africa - lynestrenol - tablets - 0.5

Lutonix 018 Drug Coated Balloon PTA Catheter Model 9014 - Peripheral angioplasty balloon catheter, drug-eluting Australia - inglés - Department of Health (Therapeutic Goods Administration)

lutonix 018 drug coated balloon pta catheter model 9014 - peripheral angioplasty balloon catheter, drug-eluting

bard australia pty ltd - 62551 - peripheral angioplasty balloon catheter, drug-eluting - lutonix 018 dcb consists of an over the wire catheter with a drug coated balloon fixed at the distal tip. the balloon is coated with a specialized formulation that includes the drug paclitaxel. the catheter is 0.018" guidewire compatible with a low profile semi-compliant balloon & low profile tapered tip to facilitate advancement. 2 radiopaque marker bands are positioned on the distal portion & 1 positioned on the proximal portion of the balloon to differentiate between the distal & proximal end the lutonix? catheter is intended for use as a pta catheter to dilate stenotic or obstructive vascular lesions in the femoropopliteal arteries, and in native or synthetic arteriovenous fistulae, for the purpose of improving limb perfusion and decreasing the incidence of restenosis.